CAY10526 is an inhibitor of Y-box binding protein 1 ( YB-1 ) and microsomal prostaglandin E2 synthase 1 ( mPGES1 ). CAY10526 inhibits the production of PGE 2 by suppressing YB-1 and mPGES1. CAY10526 induces cell apoptosis ( apoptosis ) and inhibits the JAK/STAT , TGF-β/Smad3 and PI3K/AKT signaling pathways. CAY10526 can be used in research related to melanoma, prostate cancer , esophageal adenocarcinoma, T-cell lymphoma, etc.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PGE synthase | Products > Signaling Pathways > YB-1 | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > JAK | Products > Signaling Pathways > STAT | Products > Signaling Pathways > TGF-β Receptor | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > PI3K | Products > Signaling Pathways > Akt
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.